LGALS1 and renal cell carcinoma: When looking at extend of disease, galectin-1 mRNA expression for all patients with RCC failed to reach the significance level with regard to advanced disease (p = 0.058, Figure5) and lymph node metastasis (p = 0.059, Figure6).